Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management

Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common form of ischemic optic neuropathy and the second most common optic neuropathy. Patients are generally over the age of 50 years with vasculopathic risk factors (eg, diabetes mellitus, hypertension, and obstructive sleep apnea)...

Descripción completa

Detalles Bibliográficos
Autores principales: Berry, Shauna, Lin, Weijie V, Sadaka, Ama, Lee, Andrew G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628702/
https://www.ncbi.nlm.nih.gov/pubmed/29033621
http://dx.doi.org/10.2147/EB.S125311
_version_ 1783268932621172736
author Berry, Shauna
Lin, Weijie V
Sadaka, Ama
Lee, Andrew G
author_facet Berry, Shauna
Lin, Weijie V
Sadaka, Ama
Lee, Andrew G
author_sort Berry, Shauna
collection PubMed
description Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common form of ischemic optic neuropathy and the second most common optic neuropathy. Patients are generally over the age of 50 years with vasculopathic risk factors (eg, diabetes mellitus, hypertension, and obstructive sleep apnea). The exact mechanism of NAION is not fully understood. In addition, several treatment options have been proposed. This article summarizes the current literature on the diagnosis, treatment, and management of NAION.
format Online
Article
Text
id pubmed-5628702
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-56287022017-10-13 Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management Berry, Shauna Lin, Weijie V Sadaka, Ama Lee, Andrew G Eye Brain Review Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common form of ischemic optic neuropathy and the second most common optic neuropathy. Patients are generally over the age of 50 years with vasculopathic risk factors (eg, diabetes mellitus, hypertension, and obstructive sleep apnea). The exact mechanism of NAION is not fully understood. In addition, several treatment options have been proposed. This article summarizes the current literature on the diagnosis, treatment, and management of NAION. Dove Medical Press 2017-09-27 /pmc/articles/PMC5628702/ /pubmed/29033621 http://dx.doi.org/10.2147/EB.S125311 Text en © 2017 Berry et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Berry, Shauna
Lin, Weijie V
Sadaka, Ama
Lee, Andrew G
Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management
title Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management
title_full Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management
title_fullStr Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management
title_full_unstemmed Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management
title_short Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management
title_sort nonarteritic anterior ischemic optic neuropathy: cause, effect, and management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628702/
https://www.ncbi.nlm.nih.gov/pubmed/29033621
http://dx.doi.org/10.2147/EB.S125311
work_keys_str_mv AT berryshauna nonarteriticanteriorischemicopticneuropathycauseeffectandmanagement
AT linweijiev nonarteriticanteriorischemicopticneuropathycauseeffectandmanagement
AT sadakaama nonarteriticanteriorischemicopticneuropathycauseeffectandmanagement
AT leeandrewg nonarteriticanteriorischemicopticneuropathycauseeffectandmanagement

Ejemplares similares